Top compounds associated with response to CLDN34


Feature Type Standardized
Nominal ANOVA
mRNA istradefylline CTRPv2 pan-cancer AAC 0.018 0.8
mRNA GW843682X CTRPv2 pan-cancer AAC 0.011 0.8
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.8
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.8
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA erismodegib CTRPv2 pan-cancer AAC 0.012 0.8
Download CSV